First results on the DCVax phase III trial: raising more questions than providing answers

Neuro Oncol. 2018 Sep 3;20(10):1283-1284. doi: 10.1093/neuonc/noy125.
No abstract available

MeSH terms

  • Brain Neoplasms / immunology
  • Brain Neoplasms / pathology
  • Brain Neoplasms / therapy*
  • Cancer Vaccines / immunology
  • Cancer Vaccines / therapeutic use*
  • Clinical Trials, Phase III as Topic
  • Dendritic Cells / immunology
  • Dendritic Cells / transplantation*
  • Glioblastoma / immunology
  • Glioblastoma / pathology
  • Glioblastoma / therapy*
  • Humans
  • Survival Rate
  • Treatment Outcome

Substances

  • Cancer Vaccines